SINNOVIAL has a total of 11 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2017. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets computer technology and measurement are GENOS D O O, INFANDX AG and METABOLOMIC DIAGNOSTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Bioinformatics | |
#3 | Computational chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Gaudin Philippe | 11 |
#2 | Baillet Athan | 11 |
#3 | Nguyen Minh Vu Chuong | 9 |
#4 | Courtier Anaïs | 8 |
#5 | Gottenberg Jacques-Eric | 7 |
#6 | Courtier Anais | 3 |
#7 | Guigue Lisa | 2 |
#8 | Nguyen Chuong | 2 |
Publication | Filing date | Title |
---|---|---|
FR3095698A1 | Method for estimating the efficacy of treatment with an anti-CD20 agent in a patient with rheumatoid arthritis and in inadequate response to at least one biotherapy | |
FR3090884A1 | METHOD OF ESTIMATING THE EFFECTIVENESS OF TREATMENT BY AN ANTI-TNF ALPHA AGENT IN A PATIENT WITH RHEUMATOID POLYARTHRITIS AND IN AN INADEQUATE RESPONSE TO AT LEAST ONE BIOTHERAPY | |
EP3698143A1 | Method for estimating the effectiveness against rheumatoid arthritis of a co-stimulation modulator of t-lymphocytes | |
FR3071616A1 | METHOD OF ESTIMATING THE EFFECTIVENESS OF TREATMENT BY AN IL-6 ANTI-RECEPTOR AGENT IN A PATIENT WITH RHEUMATOID ARTHRITIS AND NATIVE OF ANY BIOTHERAPY |